These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3943783)

  • 21. The effect of halothane, isoflurane, and blood loss on hepatotoxicity and hepatic oxygen availability in phenobarbital-pretreated hypoxic rats.
    Gelman S; Rimerman V; Fowler KC; Bishop SP; Bradley EL
    Anesth Analg; 1984 Nov; 63(11):965-72. PubMed ID: 6496981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological results of the rat liver after the application of halothane and hypoxia.
    Leinweber B; Cüppers M; L'Allemand H
    Acta Hepatogastroenterol (Stuttg); 1974 Oct; 21(5):364-72. PubMed ID: 4450992
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunity to halothane metabolite-modified proteins in halothane hepatitis.
    Kenna JG; Knight TL; van Pelt FN
    Ann N Y Acad Sci; 1993 Jun; 685():646-61. PubMed ID: 8363272
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of anticonvulsant agents on halothane-induced liver injury in human subjects and experimental animals.
    Nomura F; Hatano H; Ohnishi K; Akikusa B; Okuda K
    Hepatology; 1986; 6(5):952-6. PubMed ID: 3093358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics and the halothane hepatitis mystery.
    Brown BR
    Anesthesiology; 1981 Aug; 55(2):93-4. PubMed ID: 7258720
    [No Abstract]   [Full Text] [Related]  

  • 26. Factors influencing halothane hepatotoxicity in the rat hypoxic model.
    Jee RC; Sipes IG; Gandolfi AJ; Brown BR
    Toxicol Appl Pharmacol; 1980 Feb; 52(2):267-77. PubMed ID: 6767300
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of the repeated administration of halothane on the liver of the horse.
    Gopinath C; Jones RS; Ford EJ
    J Pathol; 1970 Oct; 102(2):107-14. PubMed ID: 4102168
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatic toxicity of halothane].
    Saint-Maurice Cl; Laguenie G; Couturier C
    Med Chir Dig; 1979; 8(5):427-9. PubMed ID: 534021
    [No Abstract]   [Full Text] [Related]  

  • 29. Halothane.
    Winkler K; Sejersen P; Rask H
    Lancet; 1965 Oct; 2(7418):902-3. PubMed ID: 4158364
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ultrastructural changes in rat hepatocytes after prolonged exposure to nonanesthtic doses of halothane and enflurane].
    Novelli GP; Bani-Sacchi T; Peduto VA; Pieraccioli E
    Boll Soc Ital Biol Sper; 1976 Dec; 52(23):1964-6. PubMed ID: 1027467
    [No Abstract]   [Full Text] [Related]  

  • 31. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury.
    Njoku D; Laster MJ; Gong DH; Eger EI; Reed GF; Martin JL
    Anesth Analg; 1997 Jan; 84(1):173-8. PubMed ID: 8989020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-acetylcysteine protection against halothane hepatotoxicity:experiments in rats.
    Keaney NP; Cocking G
    Lancet; 1981 Jul; 2(8237):95. PubMed ID: 6113470
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative toxicities of halothane, isoflurane, and diethyl ether at subanesthetic concentrations in laboratory animals.
    Stevens WC; Eger EI; White A; Halsey MJ; Munger W; Gibbons RD; Dolan W; Shargel R
    Anesthesiology; 1975 Apr; 42(4):408-19. PubMed ID: 1119708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halothane hepatitis: attempt to develop an animal model.
    Neuberger JM; Kenna JG; Williams R
    Int J Immunopharmacol; 1987; 9(2):123-31. PubMed ID: 2438240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic differences in reductive metabolism and hepatotoxicity of halothane in three rat strains.
    Gourlay GK; Adams JF; Cousins MJ; Hall P
    Anesthesiology; 1981 Aug; 55(2):96-103. PubMed ID: 7258721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Etiological factors in halothane hepatoxicity].
    Cousins MJ
    Cah Anesthesiol; 1987 Oct; 35(6 Suppl):7-14. PubMed ID: 3676905
    [No Abstract]   [Full Text] [Related]  

  • 37. Halothane anesthesia does not exacerbate hepatic dysfunction in cirrhotic rats.
    Maze M; Smith CM; Baden JM
    Anesthesiology; 1985 Jan; 62(1):1-5. PubMed ID: 3966663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia and halothane metabolism in vivo: release of inorganic fluoride and halothane metabolite binding to cellular constituents.
    Widger LA; Gandolfi AJ; Van Dyke RA
    Anesthesiology; 1976 Mar; 44(3):197-201. PubMed ID: 1267885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic injury associated with halogenated anaesthetics: cross-sensitization and its clinical implications.
    Mikatti NE; Healy TE
    Eur J Anaesthesiol; 1997 Jan; 14(1):7-14. PubMed ID: 9049552
    [No Abstract]   [Full Text] [Related]  

  • 40. [Halothane hepatitis and lymphocyte stimulation test].
    Saito K; Nishioka K; Iwatsuki K
    Masui; 1975 Aug; 24(8):775-9. PubMed ID: 1172547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.